Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Papi

Showing results (311-320 of 430) with videos related to

Pageof 43
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|December 4, 2020
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPDSimon Wan Yau Ming, John Haughney, Dermot Ryan, et al.
Biomedicines|December 24, 2021
Assessing Treatment Success or Failure as an Outcome in Randomised Clinical Trials of COPD Exacerbations. A Meta-Epidemiological StudyAlexander G Mathioudakis, Sachin Ananth, Thomas Bradbury, et al.
Allergy|August 2, 2020
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatmentsEnrico Heffler, Aikaterini Detoraki, Marco Contoli, et al.
The European Respiratory Journal|September 7, 2023
European Respiratory Society short guidelines for the use of as-needed ICS/formoterol in mild asthmaAlberto Papi, Diogenes S Ferreira, Ioana Agache, et al.
Eclinicalmedicine|December 8, 2025
An anti-inflammatory reliever algorithm approach to asthma management in adults: an open-label, single-arm trialPepa Bruce, Claire Houghton, Lee Hatter, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 13, 2024
Asthma remission one, none and one-hundred thousand: the relevance of the patient's viewMatteo Bonini, Simona Barbaglia, Gianna Camiciottoli, et al.
The Journal of Allergy and Clinical Immunology|April 27, 2018
Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbationsJie Zhu, Simon D Message, Patrick Mallia, et al.
NPJ Primary Care Respiratory Medicine|December 6, 2019
A multinational observational study identifying primary care patients at risk of overestimation of asthma controlVicky Kritikos, David Price, Alberto Papi, et al.
Journal of Asthma and Allergy|October 29, 2020
The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care PatientsVicky Kritikos, David Price, Alberto Papi, et al.
The Lancet. Respiratory Medicine|February 15, 2026
Budesonide-glycopyrronium-formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trialsAlberto Papi, Robert A Wise, David J Jackson, et al.
Pageof 43

Showing results (311-320 of 430) with videos related to

Sort By:
Pageof 43
International Journal of Chronic Obstructive Pulmonary Disease|December 4, 2020
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPDSimon Wan Yau Ming, John Haughney, Dermot Ryan, et al.
Biomedicines|December 24, 2021
Assessing Treatment Success or Failure as an Outcome in Randomised Clinical Trials of COPD Exacerbations. A Meta-Epidemiological StudyAlexander G Mathioudakis, Sachin Ananth, Thomas Bradbury, et al.
Allergy|August 2, 2020
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatmentsEnrico Heffler, Aikaterini Detoraki, Marco Contoli, et al.
The European Respiratory Journal|September 7, 2023
European Respiratory Society short guidelines for the use of as-needed ICS/formoterol in mild asthmaAlberto Papi, Diogenes S Ferreira, Ioana Agache, et al.
Eclinicalmedicine|December 8, 2025
An anti-inflammatory reliever algorithm approach to asthma management in adults: an open-label, single-arm trialPepa Bruce, Claire Houghton, Lee Hatter, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 13, 2024
Asthma remission one, none and one-hundred thousand: the relevance of the patient's viewMatteo Bonini, Simona Barbaglia, Gianna Camiciottoli, et al.
The Journal of Allergy and Clinical Immunology|April 27, 2018
Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbationsJie Zhu, Simon D Message, Patrick Mallia, et al.
NPJ Primary Care Respiratory Medicine|December 6, 2019
A multinational observational study identifying primary care patients at risk of overestimation of asthma controlVicky Kritikos, David Price, Alberto Papi, et al.
Journal of Asthma and Allergy|October 29, 2020
The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care PatientsVicky Kritikos, David Price, Alberto Papi, et al.
The Lancet. Respiratory Medicine|February 15, 2026
Budesonide-glycopyrronium-formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trialsAlberto Papi, Robert A Wise, David J Jackson, et al.
Pageof 43